From: The treatment of sarcoptic mange in wildlife: a systematic review
Treated species and reference | Reason for exclusion |
---|---|
Vicuna (Vicugna vicugna), Gomez-Puerta et al. [53] | No treatment outcomes are described |
Giraffe (Giraffa reticulata), Alasaad et al. [54] | Although reportedly successful on a population level, the study failed to recapture treated individuals and monitor their response to treatment |
Capybara (Hydrochoerus hydrochaeris), Bernal et al. [55] | No treatment outcomes are described |
Agile wallaby (Macropus agilis), McLelland et al. [37] | Although reportedly successful on an individual level, no post-treatment monitoring period is described |
Gorilla (Gorilla beringei beringei), Graczyk et al. [22] | Although reportedly successful on an individual level, the study fails to specify the duration of their post-treatment monitoring period |
Iberian ibex (Capra pyrenaica), Pérez et al. [56] | Limited treatment outcomes are described and there is no post-treatment monitoring period |
Gray wolf (Canis lupus), Schultz et al. [17] | Although reportedly successful on an individual level, the diagnosis of sarcoptic mange is not confirmed by skin scrapings |
Wild ruminants, Yeruham et al. [16] | Although reportedly successful on a population level, the study fails to specify the duration of their post-treatment monitoring period |
Koala (Phascolarctos cinereus), Brown et al. [40] | The study does not specify the number of animals treated or recovered |
Koala, Barker [38] | Although reportedly successful on an individual level, no post-treatment monitoring period is described |